VIV — Vivendi SE Balance Sheet
0.000.00%
- €2.58bn
- €5.16bn
- €297.00m
- 17
- 60
- 80
- 50
Annual balance sheet for Vivendi SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,111 | 4,464 | 2,554 | 2,220 | 109 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,610 | 5,140 | 5,004 | 6,378 | 122 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 8,433 | 10,721 | 9,940 | 11,216 | 239 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,193 | 1,727 | 1,580 | 1,684 | 41 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 38,122 | 33,367 | 31,280 | 38,251 | 7,929 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13,308 | 8,798 | 8,959 | 14,704 | 1,011 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 22,363 | 14,386 | 13,912 | 21,143 | 3,337 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 15,759 | 18,981 | 17,368 | 17,108 | 4,592 |
Total Liabilities & Shareholders' Equity | 38,122 | 33,367 | 31,280 | 38,251 | 7,929 |
Total Common Shares Outstanding |